Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Thomas M Siler, Craig F LaForce, Farid Kianifard, James Williams & Selwyn Spangenthal. (2014) Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients’ perceived onset of effect. International Journal of Chronic Obstructive Pulmonary Disease 9, pages 919-925.
Read now
Read now
Kazuhiro Yatera, Kei Yamasaki, Chinatsu Nishida, Shingo Noguchi, Keishi Oda, Kentarou Akata, Shuya Nagata, Yukiko Kawanami, Toshinori Kawanami, Hiroshi Ishimoto & Hiroshi Mukae. (2014) Real-world effects of two inhaled corticosteroid/long-acting β2-agonist combinations in the treatment of asthma. Journal of Asthma 51:7, pages 762-768.
Read now
Read now
Richard D O’Connor. (2011) Treatment with budesonide/formoterol pressurized metered-dose inhaler in patients with asthma: a focus on patient-reported outcomes. Patient Related Outcome Measures 2, pages 41-55.
Read now
Read now
Nashmia Qamar, Andrea A Pappalardo, Vineet M Arora & Valerie G Press. (2011) Patient-centered care and its effect on outcomes in the treatment of asthma. Patient Related Outcome Measures 2, pages 81-109.
Read now
Read now
William E. Berger & Michael J. Noonan. (2010) Treatment of Persistent Asthma With Symbicort® (Budesonide/Formoterol Inhalation Aerosol): An Inhaled Corticosteroid and Long-Acting β2-Adrenergic Agonist in One Pressurized Metered-Dose Inhaler. Journal of Asthma 47:4, pages 447-459.
Read now
Read now
Articles from other publishers (13)
Yuji Oba, Sumayya Anwer, Tinashe Maduke, Tarang Patel & Sofia Dias. (2022) Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis. Cochrane Database of Systematic Reviews 2022:12.
Crossref
Crossref
Ralph Brattsand & Olof Selroos. (2022) May a different kinetic mode explain the high efficacy/safety profile of inhaled budesonide?. Pulmonary Pharmacology & Therapeutics 77, pages 102167.
Crossref
Crossref
Iain Crossingham, Sally Turner, Sanjay Ramakrishnan, Anastasia Fries, Matthew Gowell, Farhat Yasmin, Rebekah Richardson, Philip Webb, Emily O'Boyle & Timothy SC Hinks. (2021) Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma. Cochrane Database of Systematic Reviews 2021:5.
Crossref
Crossref
Orlagh O'Shea, Elizabeth Stovold & Christopher J Cates. (2021) Regular treatment with formoterol and an inhaled corticosteroid versus regular treatment with salmeterol and an inhaled corticosteroid for chronic asthma: serious adverse events. Cochrane Database of Systematic Reviews 2021:4.
Crossref
Crossref
Aniruddha Mukhopadhyay, Mirna Waked, Jaideep Gogtay & Vaibhav Gaur. (2020) Comparing the efficacy and safety of formoterol/budesonide pMDI versus its mono-components and other LABA/ICS in patients with asthma. Respiratory Medicine 170, pages 106055.
Crossref
Crossref
Fabio Arpinelli, Mauro Carone, Gioacchino Riccardo & Giorgio Bertolotti. (2016) Health-related quality of life measurement in asthma and chronic obstructive pulmonary disease: review of the 2009-2014 literature. Multidisciplinary Respiratory Medicine 11:1.
Crossref
Crossref
Teerapol Srichana, Siwasak Juthong, Ekawat Thawithong, Supot Supaiboonpipat & Suchada Soorapan. (2016) Clinical equivalence of budesonide dry powder inhaler and pressurized metered dose inhaler. The Clinical Respiratory Journal 10:1, pages 74-82.
Crossref
Crossref
P. J. Barnes, T. B. Casale, R. Dahl, I. D. Pavord & M. E. Wechsler. (2014) The Asthma Control Questionnaire as a clinical trial endpoint: past experience and recommendations for future use. Allergy 69:9, pages 1119-1140.
Crossref
Crossref
Masayuki Hojo, Motoyasu Iikura, Junko Hirashima, Manabu Suzuki & Haruhito Sugiyama. (2014) A Comparison of Long-Term Anti-Inflammatory Effect of Two ICS/LABA Combination Inhalers; Fix-Dosed Maintenance Therapy with Budesonide/Formoterol and Salmeterol/Fluticasone. Allergology International 63:1, pages 103-111.
Crossref
Crossref
Taisuke Akamatsu, Toshihiro Shirai, Masato Kato, Dai Hashimoto, Hideki Yasui, Naoki Inui, Takafumi Suda, Koshi Yokomura, Hiroshi Hayakawa, Kyotaro Ide, Mikio Toyoshima, Shigeki Kuroishi, Kazumasa Yasuda, Hideki Suganuma, Takashi Yamada, Masafumi Masuda & Kingo Chida. (2012) Effect of Switching from Salmeterol/Fluticasone to Formoterol/Budesonide Combinations in Patients with Uncontrolled Asthma. Allergology International 61:2, pages 323-329.
Crossref
Crossref
Stephanie Korn & Roland Buhl. (2012) Efficacy of a fixed combination of ciclesonide and formoterol: The EXCITED-study. Respiratory Medicine 106:1, pages 57-67.
Crossref
Crossref
Toby J Lasserson, Giovanni Ferrara & Lucio Casali. (2011) Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children. Cochrane Database of Systematic Reviews.
Crossref
Crossref
N G Astaf'eva, I V Gamova, D Yu Kobzev, E N Udovichenko & I A Perfilova. (2011) Priverzhennost' k ingalyatsionnoyterapii i kontrol' bronkhial'noy astmy. Russian Journal of Allergy 8:1, pages 88-99.
Crossref
Crossref